ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

NIC Grants Appeals Process Explained

April 19, 1985

Obituary: Sir Richard Doll, 92, epidemiologist who linked smoking to lung cancer.

July 29, 2005

In Brief: Arlan Gottlieb, CALGB Leader, Dead At 55; NCI’s John Cooper Undergoes Heart Transplant

July 7, 1989

In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director

March 21, 1986

Six Surgical Oncology Grants To Be Funded

June 8, 1984

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011